627466-84-6

Basic information

• Product Name: 2,3,4,6-TETRA-O-BENZOYL-D-GALACTOPYRANOSIDE
• Synonyms: 2,3,4,6-TETRA-O-BENZOYL-D-GALACTOPYRANOSIDE
• CAS NO: 627466-84-6
• Molecular Formula: C₃₄H₂₈O₁₀
• Molecular Weight: 596.58012
• Product Categories: Carbohydrates & Derivatives
• Mol File: 627466-84-6.mol

Chemical Properties

• Melting Point: 171-174 °C
• Boiling Point: 744.2±60.0 °C(Predicted)
• Appearance: /
• Density: 1.38±0.1 g/cm3(Predicted)
• Storage Temp.: Refrigerator
• Solubility: Chloroform (Slightly), Methanol (Slightly)
• PKA: 11.20±0.70(Predicted)
• CAS DataBase Reference: 2,3,4,6-TETRA-O-BENZOYL-D-GALACTOPYRANOSIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3,4,6-TETRA-O-BENZOYL-D-GALACTOPYRANOSIDE(627466-84-6)
• EPA Substance Registry System: 2,3,4,6-TETRA-O-BENZOYL-D-GALACTOPYRANOSIDE(627466-84-6)

Safety Data

• Hazardous Substances Data: 627466-84-6(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
2,3,4,6-TETRA-O-BENZOYL-D-GALACTOPYRANOSIDE is used as a key intermediate in organic synthesis for the development of complex organic molecules and pharmaceutical compounds. Its unique structure allows for the creation of a wide range of derivatives, making it a versatile building block in the synthesis of various organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2,3,4,6-TETRA-O-BENZOYL-D-GALACTOPYRANOSIDE is used as a starting material for the synthesis of novel drug candidates. Its chemical properties enable the development of innovative therapeutic agents with potential applications in treating various diseases and medical conditions.
Used in Chemical Research:
2,3,4,6-TETRA-O-BENZOYL-D-GALACTOPYRANOSIDE is also employed in chemical research as a model compound for studying the properties and reactivity of similar structures. This helps researchers gain a deeper understanding of the underlying chemical principles and mechanisms, which can be applied to the design and synthesis of new molecules with specific functions and applications.

Upstream product

• 2592-58-7 1,2,3,4,6-penta-O-benzoyl-α-D-galactopyranoside 
• 61198-88-7 2,3,4,6-tetra-O-benzoyl-α-D-galactopyranosyl bromide 
• 2592-58-7 1,2,3,4,6-Penta-O-benzoyl-α-D-galactopyranose 
• 105376-04-3 ethyl 2,3,4,6-tetra-O-benzoyl-1-thio-β-D-galactopyranoside 
• 3646-73-9 α-D-galactopyranose 
• 98-88-4 benzoyl chloride 
• 10257-28-0 D-Galactose 
• 48149-72-0 (2S,3R,4S,5R,6R)-2-Allyloxy-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol 
• 149707-75-5 2,3,4,6-tetra-O-benzoyl-1-O-trichloroacetimidoyl-α-D-galactopyranose 
• 188435-38-3 bromide 2,3,4,6-tetra-O-Bz-α-D-galactopyranosyl bromide 
• 7296-64-2 β-D-galactopyranoside 
• 1423987-85-2 C₃₆H₃₃NO₁₀ 

Downstream Products

• 149707-75-5 2,3,4,6-tetra-O-benzoyl-1-O-trichloroacetimidoyl-α-D-galactopyranose 
• 233674-87-8 2,3,4,6-Tetra-O-benzoyl-β-D-galactopyranosyl S-(2-pyridyl) thiocarbonate 
• 158852-06-3 2,3,4,6-tetra-O-benzoyl-α-D-galactopyranosyl chloride 
• 1355331-87-1 5-(N-benzyloxycarbonyl)-aminopentyl 2,3,4,6-tetra-O-benzoyl-β-D-galactopyranoside 
• 1390620-14-0 ergosterol-3-O-(2,3,4,6-tetra-O-benzoyl-β-D-galactopyranoside) 
• 203435-09-0 2,3,4,6-tetra-O-benzoyl-α,b-D-galactopyranosyl trichloroacetimidate 
• 1423987-85-2 C₃₆H₃₃NO₁₀ 
• 188435-38-3 bromide 2,3,4,6-tetra-O-Bz-α-D-galactopyranosyl bromide 
• 259533-66-9 C₄₁H₃₅NO₁₀ 

Relevant articles and documents

Carbon tetrachloride-free allylic halogenation-mediated glycosylations of allyl glycosides

The allylic bromination of allyl glycosides is conducted using NBS/AIBN reagents in (EtO)2CO and PhCF3 solutions, without using CCl4 as a solvent. The activated mixed halo-allyl glycosides led to glycosylations, mediated by a triflate, in a latent-active

Synthesis of the hexasaccharide from Trypanosoma cruzi mucins with the Galp(1?→?2)Galf unit constructed with a superarmed thiogalactopyranosyl donor

Hexasaccharide β-D-Galp-(1→ 2)-[β-D-Galp-(1 → 3)]-β-D-Galp-(1 → 6)-[β-D-Galp-(1 → 2)-β-D-Galf-(1 → 4)]-D-GlcNAc (1) was found O-linked in mucins of Trypanosoma cruzi epimastigotes and metacyclic trypomatigotes. Studies on the biological pathways and functionalities of the mucin oligosaccharides are prompted in order to understand the interactions of these molecules with the insect host. Trisaccharide constituent β-D-Galp-(1 → 2)-β-D-Galf-(1 → 4)-D-GlcNAc was constructed from the reducing to the non-reducing end. We discuss the difficulties to introduce a Galp unit at the O-2 position of a partially protected galactofuranosyl unit which were overcome using an anchimerically superarmed donor. By this route and employing a [3 + 3] nitrilium convergent approach hexasaccharide 1 was synthesized in moderate yield.

ENDOSOMAL CLEAVABLE LINKERS

The present disclosure relates generally to cleavable linkers and uses thereof.

The dehydroepiandrosterone and dehydroepiandrosterone alkone glycosylation derivative and its preparation method and application

The invention discloses epiandrosterone glycosylation derivatives and dehydrogenated epiandrosterone glycosylation derivatives, and a preparation method thereof. The preparation method comprises the following steps: respectively carrying out coupling reac

3 - monosaccharide acid oxygen glucoside oleanolic alkane type and wusu alkane triterpene saponin derivative and its preparation method and application

The invention discloses a 3-monouronic acid o-glycoside oleanane type and ursane type triterpenoid saponin derivative. The derivative has a structural formula as shown in the specification, wherein R4 is one of H atom, alkyl containing 1-10 carbons, alkyl

A new method for selective deprotection of anomeric N,O -dimethylhydroxylamine promoted by TMSCl

TMSCl was shown to be an efficient reagent for selective deprotection of the anomeric position protected as N,O-dimethylhydroxylamine glycoside. This deprotection condition was proved to be compatible with a number of protecting groups, such as the TBDPS, acetyl, benzyl, benzylidene, and benzoyl groups.Copyright Taylor and Francis Group, LLC.

Synthesis of a chlorogenin glycoside library using an orthogonal protecting group strategy

Naturally occurring spirostanol saponins bear a chacotriose, α-l-rhamnopyranosyl-(1→2)-[α-l-rhamnopyranosyl-(1→4)] -β-d-glucopyranose residue as the oligosaccharide moiety which is believed to be important for biological activity. Herein the development of a concise, combinatorial method for the synthesis of two series of glycan variants at the 2′ and/or 4′ positions of chacotriose is described and the structure-activity relationships of the glycone part at 3-OH of chlorogenin investigated. These compounds were found to be weakly-cytotoxic toward leukemia cell lines CCRF and HL-20, indicating that the chacotriose moiety is important for anticancer activity.

Trichloroisocyanuric acid (TCCA): An efficient green reagent for activation of thioglycosides toward hydrolysis

Trichloroisocyanuric acid (TCCA), an inexpensive, commercially available, and non-toxic reagent has been used for the activation of thioglycosides toward their hydrolysis to the corresponding hemiacetals in high to excellent yields. The methodology provides a mild reaction condition for dealing with compounds containing acid sensitive functional groups.

Highly efficient synthesis and antitumor activity of monosaccharide saponins mimicking components of Chinese folk medicine Cordyceps sinensis

Ergosterol 3-O-β-d-glucopyranoside (1a) and ergosterol 3-O-d-galactopyranoside (1b) were highly efficiently synthesized and evaluated for their inhibitory activities against two tumor cell lines. The structures of these compounds were extensively confirmed by 1H, 13C NMR, IR, and HRMS. Compounds 1a and 1b exhibited interesting cytotoxic profiles. The antitumor activity of compound 1a was higher than that of 1b.

Mitochondrial affinity of guanidine-rich molecular transporters built on monosaccharide scaffolds: Stereochemistry and lipophilicity

We synthesized eight G8 molecular transporters (MTs) based on 4 different monosaccharide scaffolds, and studied their biological properties with a special focus on possible mitochondrial targeting and tissue selectivity. The mitochondrial affinity of these MTs was found to be clearly related to the scaffold stereochemistry and also tenuously with the lipophilicity. It may be suggested that in the practical delivery strategy of drugs for the brain and mitochondrial diseases the BBB permeability and mitochondrial affinity should be considered as key parameters, and that an enhanced mitochondrial affinity appears possible by further research on the structure-property relationship of guanidine-rich molecular transporters.